This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Massiera, F. Articles by Teboul, M. Search for Related Content PubMed PubMed Citation Articles by Massiera, F. Articles by Teboul, M.

Angiotensinogen-Deficient Mice Exhibit Impairment of Diet-Induced Weight Gain with Alteration in Adipose Tissue Development and Increased Locomotor Activity

Centre National de la Recherche Scientifique 6543, Centre de Biochimie (F.M., P.S.-M., R.N., G.A., M.T.), Nice 06108, France; University Medical Center, Department of Physiology, Faculty of Medicine (J.S.), Genève, 1211, Switzerland; INSERM, U-352, Institut National des Sciences Appliquées (A.G.), Villeurbanne 69100, France; INSERM, U-465 (A.Q.-B., S.T.), Paris 75270, France; and University of Tsukuba (A.F.), Tsukuba, Ibaraki 305, Japan

Address all correspondence and requests for reprints to: Dr. Gérard Ailhaud, Centre de Biochimie, UMR 6543, Centre National de la Recherche Scientifique, Université de Nice-Sophia Antipolis, Faculté des Sciences, Parc Valrose, 06108 Nice Cedex 2, France.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
White adipose tissue is known to contain the components of the renin-angiotensin system, which gives rise to angiotensin II from angiotensinogen (AGT). Recent evidence obtained in vitro and ex vivo is in favor of angiotensin II acting as a trophic factor of adipose tissue development. To determine whether AGT plays a role in vivo in this process, comparative studies were performed in AGT-deficient (agt^-/-) mice and control wild-type mice. The results showed that agt^-/- mice gain less weight than wild-type mice in response to a chow or high fat diet. Adipose tissue mass from weaning to adulthood appeared altered rather specifically, as both the size and the weight of other organs were almost unchanged. Food intake was similar for both genotypes, suggesting a decreased metabolic efficiency in agt^-/- mice. Consistent with this hypothesis, cellularity measurement indicated hypotrophy of adipocytes in agt^-/- mice with a parallel decrease in the fatty acid synthase activity. Moreover, AGT-deficient mice exhibited a significantly increased locomotor activity, whereas metabolic rate and mRNA levels of uncoupling proteins remained similar in both genotypes. Thus, AGT appears to be involved in the regulation of fat mass through a combination of decreased lipogenesis and increased locomotor activity that may be centrally mediated.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
ANGIOTENSINOGEN (AGT), the unique substrate of renin, is the precursor of angiotensin I (AngI) that gives rise to active angiotensin II (AngII) through the action of AngI-converting enzyme. The renin-angiotensin system is known to have a major role in the regulation of blood pressure and fluid and sodium homeostasis (1). White adipose tissue (WAT) is an important extrahepatic production site of AGT (2), and several reports have suggested the existence of a functional renin-angiotensin system in this tissue. In isolated adipocytes and cultured adipose cells from rodents and human, recent data have shown the presence of 1) renin, by RT-PCR, and renin-like activity; 2) AngI-converting enzyme, by RT-PCR and Western blot; and 3) AngII production (3, 4, 5). In addition to the systemic effect of AngII in the regulation of blood pressure, various roles of AGT via locally produced AngII have been proposed: 1) at the time of adipose tissue development, AngII appears to be a trophic factor that is involved in organogenesis of rodent, primate, and human fetuses (6); 2) AngII has been implicated in cell cycle progression of human preadipocytes, the cell type that precedes the formation of nondividing adipocytes (7); 3) both in vitro and in vivo, AngII stimulates the production and release of prostacyclin from adipocytes, which, in turn, stimulates adipogenesis of adipose precursor cells (8, 9); and 4) AngII increases lipogenesis and triglyceride accumulation in 3T3-L1 preadipose cells and human adipocytes (10), consistent with the observation that rats treated with an oral AngII receptor antagonist (losartan) exhibit a decrease in adipocyte size (11). In contrast to liver cells, in which numerous hormones have been shown to enhance AGT mRNA levels and AGT secretion, adipose cells respond only to fatty acids and glucocorticoids, which are known to be implicated in the hyperplastic and hypertrophic growth of WAT (12, 13). Collectively, these studies indicate that AngII plays a local role in the development of adipose tissue and its cellularity, i.e. fat cell number and size. To gain a better understanding of the effects of AngII on adipose tissue growth, we examined the comparative development of WAT and brown adipose tissue (BAT) in wild-type (WT) and AGT-deficient (agt^-/-) mice in response to a standard chow or a high fat diet.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mice
Generation of agt^-/- mice has been previously described. Briefly, chimeric mice were backcrossed with ICR mice for at least 10 generations (14), then 5 agt^-/- males and 15 agt^-/- females were bred to generate further generations. AGT-deficient mice reproduced normally. Although some perinatal lethality occurred, as previously reported (15), their life expectancy after weaning was not different from that of WT mice.

Only male agt^-/- mice were used in the experiments herein, and ICR-CD1 control WT mice were purchased from Harlan (Gammat, France). Animals were housed five per cage and had free access to food and water in a controlled environment with a 12-h light, 12-h dark cycle and constant temperature (22 C). At weaning, the mice were fed either a standard laboratory chow diet or a high fat diet containing 1% cholesterol, 30% corn oil (representing 65% of calories as fat), 27% carbohydrates, 11.5% proteins, and 1.9% minerals (UAR, Villemoisson, France). Body weight was assessed weekly for up to 46 wk. At the indicated times mice were killed by cervical dislocation according to French Centre National de la Recherche Scientifique ethical guidelines. Epididymal WAT, BAT, and hind limb skeletal muscle were rapidly removed and immediately used for RNA preparation.

Food consumption and feces analysis
Mice were housed individually in metabolic cages (Marty Technology, Marcilly-sur-Eure, France) for 1 wk, fed ad libitum with a standard or high fat diet, and given free access to water in a controlled environment at 22 C with a 12-h light, 12-h dark cycle. Food consumption was measured during the last 4 d as the difference between the amount of food given and that removed from the cage after the amount of any food spilled was taken into account. Similarly, feces were collected during the last 4 d of feeding, and the weight of pooled feces was determined after drying at 70 C to a constant weight. The fat content of the feces was determined by the Soxhlet extraction method using petroleum benzine.

Body weight and body composition
Body weight was measured at the same time each day. For body composition, mice were killed by cervical dislocation, and the whole carcasses were incised, dried to a constant weight at 70 C, then subsequently homogenized. Total body fat content was determined by the Soxhlet extraction method as described above. The results are presented as absolute weight (grams) and as percentage of total body weight. The fat-free mass, which includes mineral content (which accounts for 2% of fat-free mass in mice) was obtained by subtraction of body fat content from dry weight.

Adipose tissue cellularity
The size and number of adipocytes were determined as previously described (16). Briefly, fat cell size was determined by a procedure derived from a microphotometric method; micrographs of isolated cells were taken with a light microscope, and measurement of cell diameters was performed using a computer equipped with an image analyzer. Fat cell number was estimated from a portion of adipose tissue by dividing the lipid content by the average fat cell weight.

Fatty acid synthase (FAS) activities
FAS activities were assayed spectrophotometrically in crude cytosolic extracts of epididymal fat pads by measuring the oxidation of NAPDH in the presence of acetyl coenzyme A and malonyl coenzyme A (17). Data are expressed as nanomoles of NAPDH oxidized per min/mg, i.e. milliunits per mg cytosolic proteins, which were assayed by the method of Bradford (17).

Isolation and analysis of RNA
RNA was extracted using the RNeasy Midi kit according to the manufacturer’s protocol (QIAGEN, Cortaboeuf, France). Northern blot analysis was performed as described previously (18). Autoradiographs were quantified using a Fujix PhosphorImager (Tokyo, Japan). All results were normalized to ß-actin signals.

Measurements of metabolic rate and locomotor activity
For locomotor activity and metabolic rate measurements, mice were randomly and alternatively placed into the respective experimental chambers; at least 1 wk separated successive testing. Metabolic rate was measured by indirect calorimetry during 24 h. An open circuit calorimeter, as described in detail previously (19), equipped with a sensitive mass flow meter (model 5875, Brooks Instrument, Veenendaal, The Netherlands) was used. Food and water were available during testing. The ambient temperature was set at 22 C. The data were recorded every 5 sec by an on-line computerized data acquisition system (SICMU, CMU, Geneva, Switzerland). The metabolic rate was calculated using Weir’s equation and expressed in terms of watts per kg BW to the 0.75 power. For each mouse, the mean metabolic rate was calculated for the last 23 h.

For locomotor activity, the system used has been previously described (19). The home-cage traveled distance was measured during either the lights on or lights off cycle. When placed in this experimental set-up, mice did not have access to food or water. Quantitative analyses of the distance traveled during the entire period were made off-line. The fraction of time spent in activity was calculated by measuring the time during which the animal showed a displacement of its center of mass of at least 1 cm. All calculations were made using 386-Matlab (Mathworks, Sherborn, MA).

Blood parameters
Mice were anesthetized 2 h after lights on with 60 µl xylene/ketamine (1:4, vol/vol). Blood was collected by eye puncture into tubes containing citrate at a final concentration of 0.01 M. After 10 min in ice, plasma was separated by centrifugation at 10,000 x g for 10 min and stored at -20 C. A volume of 100 µl of a 1:2 dilution was used for mouse leptin assays using a commercial kit (R & D Systems, Inc., London, UK). Glucose, triglycerides, total cholesterol, and free T₃ were determined using standard laboratory procedures. Insulin was determined by RIA using a commercial kit with a rat insulin standard (CIS Biointernational, Gif-sur-Yvette, France).

Statistical analysis
All data are expressed as the mean ± SEM. The values were examined by the one-way ANOVA or t test with the computer software STATISTIX, version 4.0 (Analytical Software, Tallahassee, FL).

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
AGT-deficient mice gain less weight than WT mice in response to diets
Male agt^-/- and WT mice were fed a chow diet or a high fat diet from weaning up to 46 wk of age. Figure 1 shows that agt^-/- mice exhibited, at weaning, a lower body weight than WT mice. This difference remained throughout development and was still observed at adulthood. At 6 wk of age and thereafter, agt^-/- mice fed a chow diet weighed 21% less than WT mice. At that age, the epididymal fat pad mass of chow-fed agt^-/- mice was 2-fold lower than that of WT mice (see Table 2), and at 20 wk of age (Table 1, Exp 1), the total fat mass of agt^-/- mice, determined on whole carcasses, was 1.9-fold lower. Due to the trophic role of AngII in organogenesis, it is of interest to note that the effect of AGT deficiency was mainly confined to adipose tissue. At 6 wk of age, no effect on body length was observed (8.8 ± 0.4 cm for WT vs. 9.0 ± 0.5 for agt^-/- mice; n = 20), and only a modest effect (<1.2-fold) was detected on the weights of heart, kidney, and liver. Although fat-free mass was lower in agt^-/- mice, leanness (expressed as protein mass per g BW) was similar in agt^-/- and WT mice in adulthood (Table 1). In WT mice, a weight gain of 10–15% was induced by high fat feeding; in contrast, no weight gain but, instead, a slight decrease (6%) was observed in agt^-/- mice compared with mice fed a chow diet (Fig. 1). The lack of weight gain in agt^-/- mice fed a high fat diet could be due to lower food intake and/or defective intestinal absorption. As shown in Table 1, this was excluded, as food intake was higher in chow-fed agt^-/- than in WT mice and even higher in agt^-/- mice when corrected for body mass to the 0.75 power, consistent with similar levels of circulating leptin (see Table 3). In high fat-fed animals, food intake was slightly lower in agt^-/- mice, but, when expressed per body mass to the 0.75 power, both values were similar. Feces analysis did not show any difference in daily quantity or fat content expressed as a percentage of dry weight between WT and agt^-/- mice. Because the body composition data in Table 1 indicate that the lower body weight was partly due to a lower fat mass, a detailed analysis of WAT cellularity was performed.

View larger version (19K): [in this window] [in a new window]   Figure 1. Body weights of WT ( and ) and AGT-deficient ( and ) mice fed a chow diet ( and ) or a high fat diet ( and ) from weaning onward (n = 30).

To gain some insights on the metabolic pathways leading to triglyceride accumulation in adipocytes, measurement of endogenous fatty acid synthesis was performed by determining FAS activities of cytosolic extracts of epididymal fat pads of WT and agt^-/- mice. Data from Table 2 show that FAS activity was 2.2-fold higher in extracts from WT mice than in those from agt^-/- mice, consistent with the 2.6-fold increase observed in adipocyte weight. This observation is also in accordance with a report showing that AngII regulates lipogenesis by increasing FAS activity (10). Upon high fat feeding, it is known that the exogenous supply of fatty acids from chylomicrons increases dramatically, leading to a down-regulation of FAS activity. As shown in Table 2, this down-regulation was taking place in WT mice, but not in agt^-/- mice, suggesting that this modulation was AngII related.

AGT deficiency and thermogenesis-related parameters
Comparative analysis of the main metabolic blood parameters is shown in Table 3. Compared with WT mice, agt^-/- mice exhibited a moderate decrease in circulating levels of cholesterol and triglycerides. Although statistically significant, the increase observed in glucose levels in agt^-/- mice was slight and could not be considered physiologically important. In addition, insulin levels were similar. Upon high fat feeding, some interesting features emerged. First, glucose levels of agt^-/- mice remained unchanged, thus abolishing the slight difference observed between the two genotypes. Second, triglyceride levels were significantly decreased, whereas cholesterol levels were increased, in agreement with the responsiveness to dietary fat and cholesterol reported in various strains of inbred mice (20). Free T₃ was also determined, as this hormone has been long known to be involved in thermogenesis (21). Table 3 shows similar levels of free T₃ in chow-fed WT and agt^-/- mice. However, upon high fat feeding, the levels were significantly increased in both genotypes. Interestingly, a significant increase (1.3-fold) was observed in the level of free T₃ in agt^-/- mice compared with that in WT mice. The levels of insulin and leptin were similar in both genotypes when fed a standard chow or a high fat diet. Moreover, these data are in agreement with the fact that at 6 wk of age, no statistically significant difference between the two genotypes was observed with respect to interscapular BAT weight (59.4 ± 2.9 mg for WT mice vs. 61.9 ± 2.2 mg for agt^-/- mice; n = 12) and uncoupling protein-1 (UCP-1) mRNA levels (Fig. 2). Northern blot analysis was also performed for UCP-2 from epididymal fat pads and for UCP-3 from skeletal muscle. Using ß-actin mRNA levels as an internal standard and taking an arbitrary unit of 1 for WT mice, the values for agt^-/- mice were, respectively, 1.09 for UCP-1 (n = 9; P = NS), 1.13 for UCP-2 (n = 6; P = NS), and 1.24 for UCP-3 (n = 3; P = NS).

View larger version (78K): [in this window] [in a new window]   Figure 2. UCP RNA content of interscapular BAT, epididymal WAT, and skeletal muscle (SM) of 6-wk-old WT and AGT-deficient (agt-/-) mice.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

In contrast to WT mice, which gained weight between 12 and 46 wk of age on high fat feeding, the body weight of agt^-/- mice remained stable. Under the conditions of augmented exogenous fatty acid supply, the weight of epididymal fat pads remained 1.8-fold higher in WT mice than in agt^-/- mice at 6 wk of age, and this increase became more evident at 16 wk of age. As anticipated, during high fat feeding, hypertrophy of adipocytes occurred in agt^-/- mice, but a large difference persisted, as the weights of adipocytes of WT mice remained much higher than those of agt^-/- mice. The stable body weight of agt^-/- mice appears at odds with the increase in adipocyte size observed in the epididymal depot. However, it cannot be ruled out that the growth of this depot may not be identical to that of the other adipose depots, in a way similar to the differential growth of different adipose depots in response to nutritional or environmental stimuli (22).

In search of additional factors that could explain the lower body weight of agt^-/- mice compared with WT mice in response to a chow or a high fat diet, deficient mice show a decrease in food efficiency, as estimated by the ratio of the mean 23-h metabolic rate divided by the energy content of the food eaten by the same animal. This ratio is significantly (P < 0.001) lower in agt^-/- mice than in WT mice. This finding suggests the occurrence of activation of futile cycles in the metabolic pathways of agt^-/- mice. In looking for possible mechanisms to explain the increased energy dissipation of these mice, our data probably exclude a difference in intestinal absorption, as both the amount and the fat content of feces were similar. In addition, leptin, which is known to increase sympathetic activity (23) and energy expenditure in ob/ob mice (24), is also excluded, as circulating leptin levels were similar in the two genotypes fed either a standard or a high fat diet. In agreement with this assumption, the sympathetic pathway did not seem to be altered, as shown indirectly by UCP-1 expression levels in BAT. Free T₃ levels were similar in agt^-/- mice and WT mice fed a chow diet. Upon high fat feeding, although both genotypes increased their levels of free T₃ compared with those in chow-fed animals, a significant hyperthyroidism was seen in agt^-/- mice compared with WT mice. This additional component may contribute to lower the metabolic efficiency of AGT-deficient mice.

Locomotor activity, as expressed by the distance covered, was clearly and significantly increased in agt^-/- mice compared with WT mice and may participate to some extent in the higher energy dissipation (19). Therefore, it is assumed that the more frequent and longer activity periods of AGT-deficient mice, in addition to decreased lipogenesis, are responsible for the decreased fat deposition. It has been reported in rats that brain AGT participates in a central regulation of blood pressure (25), and it can be hypothesized that AngII affects similarly the central pathway(s) leading to increased locomotor activity. In summary, our results show that, compared with WT mice, agt^-/- mice do not gain weight in response to a high fat diet and exhibit alterations in WAT development and locomotor activity, supporting the involvement of AngII in the regulation of body fat mass.

	Acknowledgments

 
The authors thank Dr. Marie-France Masseyeff-Elbaz and Mr. Jean-Jacques René (Institut Arnault Tzanck, St. Laurent du Var, France) for performing assays of blood parameters. Thanks are also due to Dr. B. Phillips for careful reading of the manuscript, and to Mrs. Geneviève Oillaux for skillful secretarial assistance.

	Footnotes

 
This work was supported by a special grant from Bristol-Myers Squibb Foundation (to G.A.), Grant 31-57-129.99 from the Swiss National Science Foundation (to J.S.), a grant from Comité Française de Coordination des Recherches sur l’Athérosclérose et le Cholestérol (to M.T.), and a fellowship from the French Ministère de la Recherche (to F.M.).

Abbreviations: AGT, Angiotensinogen; AngII, angiotensin II; BAT, brown adipose tissue; FAS, fatty acid synthase; UCP-1, uncoupling protein-1; WAT, white adipose tissue; WT, wild-type.

Received May 7, 2001.

Accepted for publication August 20, 2001.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P 1992 Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169–80[CrossRef][Medline]
2. Cassis LA, Saye J, Peach MJ 1988 Location and regulation of rat angiotensinogen messenger RNA. Hypertension 11:591–596[Abstract/Free Full Text]
3. Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, Carlsson LM 1998 Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 83:3925–3929[Abstract/Free Full Text]
4. Schling P, Mallow H, Trindl A, Loffler G 1999 Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 23:336–341[CrossRef][Medline]
5. Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM 1999 Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 17:555–560[CrossRef][Medline]
6. Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM 1998 Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol 274:F43–F50
7. Crandall DL, Armellino DC, Busler DE, McHendry-Rinde B, Kral JG 1999 Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 140:154–158[Abstract/Free Full Text]
8. Darimont C, Vassaux G, Ailhaud G, Negrel R 1994 Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 135:2030–2036[Abstract]
9. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R 2001 Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 142:487–492[Abstract/Free Full Text]
10. Jones BH, Standridge MK, Moustaid N 1997 Angiotensin II increases lipogenesis in 3T3–L1 and human adipose cells. Endocrinology 138:1512–1519[Abstract/Free Full Text]
11. Zorad S, Fickova M, Zelezna B, Macho L, Kral JG 1995 The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity. Gen Physiol Biophys 14:383–391[Medline]
12. Safonova I, Aubert J, Negrel R, Ailhaud G 1997 Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J 322:235–239
13. Aubert J, Darimont C., Safonova I, Ailhaud G, Negrel R 1997 Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J 328:701–706
14. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K 1994 Angiotensinogen-deficient mice with hypotension. J Biol Chem 269:31334–31337[Abstract/Free Full Text]
15. Umemura S, Kihara M, Sumida Y, Yabana M, Ishigami T, Tamura K, Nyui N, Hibi K, Murakami K, Fukamizu A, Ishii M 1998 Endocrinological abnormalities in angiotensinogen-gene knockout mice: studies of hormonal responses to dietary salt loading. J Hypertens 16:285–289[CrossRef][Medline]
16. Lavau M, Susini C, Knittle J, Blanchet-Hirst S, Greenwood MR 1977 A reliable photomicrographic method to determining fat cell size and number: application to dietary obesity. Proc Soc Exp Biol Med 156:251–256[Medline]
17. Bazin R, Ferré P 2000 Assays of lipogenic enzymes. In: Ailhaud G, ed. Adipose tissue protocols. Totowa: Humana Press; 155
18. Aubert J, Saint-Marc P, Belmonte N, Dani C, Negrel R, Ailhaud G 2000 Prostacyclin IP receptor up-regulates the early expression of C/EBPß and C/EBP in preadipose cells. Mol Cell Endocrinol 160:149–156
19. Girardier L, Clark MG, Seydoux J 1995 Thermogenesis associated with spontaneous activity: an important component of thermoregulatory needs in rats. J Physiol 488:779–787[Medline]
20. Kirk EA, Moe GL, Caldwell MT, Lernmark JA, Wilson DL, LeBoeuf RC 1995 Hyper- and hypo-responsiveness to dietary fat and cholesterol among inbred mice: searching for level and variability genes. J Lipid Res 36:1522–1532[Abstract]
21. Silva JE 1995 Thyroid hormone control of thermogenesis and energy balance. Thyroid 5:481–492[Medline]
22. Faust IM, Miller WH 1983 Hyperplastic growth of adipose tissue in obesity. In: Angel A, Hollenberg CH, Roncari AK, eds. The adipocyte and obesity, cellular and molecular mechanisms. New York: Raven Press; 51
23. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI 1997 Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100:270–278[Medline]
24. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543–546[Abstract/Free Full Text]
25. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M 1999 Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci USA 96:3975–3980[Abstract/Free Full Text]

This article has been cited by other articles:

				A. P. Jayasooriya, M. L. Mathai, L. L. Walker, D. P. Begg, D. A. Denton, D. Cameron-Smith, G. F. Egan, M. J. McKinley, P. D. Rodger, A. J. Sinclair, et al. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance PNAS, May 6, 2008; 105(18): 6531 - 6536. [Abstract] [Full Text] [PDF]

				M. J. McKinley, L. L. Walker, T. Alexiou, A. M. Allen, D. J. Campbell, R. Di Nicolantonio, B. J. Oldfield, and D. A. Denton Osmoregulatory fluid intake but not hypovolemic thirst is intact in mice lacking angiotensin Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1533 - R1543. [Abstract] [Full Text] [PDF]

				H. J Milionis, M. S Kostapanos, K. Vakalis, I. Theodorou, I. Bouba, R. Kalaitzidis, I. Georgiou, M. S Elisaf, and K. C Siamopoulos Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome Journal of Renin-Angiotensin-Aldosterone System, December 1, 2007; 8(4): 181 - 189. [Abstract] [PDF]

				A. Whaley-Connell, B. S. Pavey, K. Chaudhary, G. Saab, and J. R. Sowers Review: Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 27 - 35. [Abstract] [PDF]

				V. Achard, S. Boullu-Ciocca, R. Desbriere, G. Nguyen, and M. Grino Renin receptor expression in human adipose tissue Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R274 - R282. [Abstract] [Full Text] [PDF]

				D. J. Adams, G. A. Head, M. A. Markus, F. J. Lovicu, L. van der Weyden, F. Kontgen, M. J. Arends, S. Thiru, D. N. Mayorov, and B. J. Morris Renin Enhancer Is Critical for Control of Renin Gene Expression and Cardiovascular Function J. Biol. Chem., October 20, 2006; 281(42): 31753 - 31761. [Abstract] [Full Text] [PDF]

				M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]

				S. O. Kasper, C. S. Carter, C. M. Ferrario, D. Ganten, L. F. Ferder, W. E. Sonntag, P. E. Gallagher, and D. I. Diz Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain renin-angiotensin systems Physiol Genomics, November 17, 2005; 23(3): 311 - 317. [Abstract] [Full Text] [PDF]

				R. Kouyama, T. Suganami, J. Nishida, M. Tanaka, T. Toyoda, M. Kiso, T. Chiwata, Y. Miyamoto, Y. Yoshimasa, A. Fukamizu, et al. Attenuation of Diet-Induced Weight Gain and Adiposity through Increased Energy Expenditure in Mice Lacking Angiotensin II Type 1a Receptor Endocrinology, August 1, 2005; 146(8): 3481 - 3489. [Abstract] [Full Text] [PDF]

				L. Yvan-Charvet, P. Even, M. Bloch-Faure, M. Guerre-Millo, N. Moustaid-Moussa, P. Ferre, and A. Quignard-Boulange Deletion of the Angiotensin Type 2 Receptor (AT2R) Reduces Adipose Cell Size and Protects From Diet-Induced Obesity and Insulin Resistance Diabetes, April 1, 2005; 54(4): 991 - 999. [Abstract] [Full Text] [PDF]

				Y Inokuchi, T Morohashi, I Kawana, Y Nagashima, M Kihara, and S Umemura Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice Gut, March 1, 2005; 54(3): 349 - 356. [Abstract] [Full Text] [PDF]

				A. Prasad and A. A. Quyyumi Renin-Angiotensin System and Angiotensin Receptor Blockers in the Metabolic Syndrome Circulation, September 14, 2004; 110(11): 1507 - 1512. [Full Text] [PDF]

				E. E. Kershaw and J. S. Flier Adipose Tissue as an Endocrine Organ J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2548 - 2556. [Abstract] [Full Text] [PDF]

				A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers Hypertension and Obesity Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205. [Abstract] [Full Text]

				F. Massiera, P. Saint-Marc, J. Seydoux, T. Murata, T. Kobayashi, S. Narumiya, P. Guesnet, E.-Z. Amri, R. Negrel, and G. Ailhaud Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J. Lipid Res., February 1, 2003; 44(2): 271 - 279. [Abstract] [Full Text] [PDF]

				P. Valet, G. Tavernier, I. Castan-Laurell, J. S. Saulnier-Blache, and D. Langin Understanding adipose tissue development from transgenic animal models J. Lipid Res., June 1, 2002; 43(6): 835 - 860. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Massiera, F. Articles by Teboul, M. Search for Related Content PubMed PubMed Citation Articles by Massiera, F. Articles by Teboul, M.